CXCR2 overexpression in human lung cancer tissue has been linked to a poor prognosis, while CXCR2 agonists have been proposed as potential diagnostic biomarkers in pancreatic cancer patients [269,270]. Here, CXCR2 is linked to lung carcinoma.